Benjamin Edwards Inc Anixa Biosciences Inc Transaction History
Benjamin Edwards Inc
- $8.36 Billion
- Q3 2025
A detailed history of Benjamin Edwards Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Benjamin Edwards Inc holds 11,200 shares of ANIX stock, worth $43,680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,200
Previous 11,200
-0.0%
Holding current value
$43,680
Previous $36,000
2.78%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
70Shares Held
5.33MCall Options Held
14.1KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA1.39MShares$5.43 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC617KShares$2.41 Million0.28% of portfolio
-
D.A. Davidson & Co.614KShares$2.4 Million0.01% of portfolio
-
Ubs Group Ag505KShares$1.97 Million0.0% of portfolio
-
Mission Wealth Management, LP356KShares$1.39 Million0.02% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $120M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...